Lista de obras - Giuseppe A. Sautto - Dominio Público Uruguay

A Biologically-validated HCV E1E2 Heterodimer Structural Model

artículo científico publicado en 2017

A Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin

scientific article published on 06 December 2019

A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments.

artículo científico publicado en 2012

Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections

artículo científico publicado en 2015

Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines

artículo científico publicado en 2019

An Influenza Virus Hemagglutinin Computationally Optimized Broadly Reactive Antigen Elicits Antibodies Endowed with Group 1 Heterosubtypic Breadth against Swine Influenza Viruses

scientific article published on 31 March 2020

Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference.

artículo científico publicado en 2012

Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study

artículo científico publicado en 2017

Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.

artículo científico publicado en 2015

Chimeric antigen receptor (CAR)-redirected T cells: is there a place for them in infectious diseases?

artículo científico publicado en 2015

Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: epitope definition and implications in risk stratification of patients under natalizumab therapy

artículo científico publicado en 2014

Convergent antibody evolution and clonotype expansion following influenza virus vaccination

artículo científico publicado en 2021

Editorial: Immunotherapeutic and Immunoprophylactic Strategies for Infectious Diseases

artículo científico publicado en 2020

Elicitation of Broadly Protective Antibodies following Infection with Influenza Viruses Expressing H1N1 Computationally Optimized Broadly Reactive Hemagglutinin Antigens

scientific article published on 27 August 2018

Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge

artículo científico publicado en 2017

HCV E2 core structures and mAbs: something is still missing.

artículo científico publicado en 2014

HCV proteins and immunoglobulin variable gene (IgV) subfamilies in HCV-induced type II mixed cryoglobulinemia: a concurrent pathogenetic role

artículo científico

Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral Genotypes

artículo científico publicado en 2009

High-Yield Expression and Purification of Recombinant Influenza Virus Proteins from Stably-Transfected Mammalian Cell Lines

artículo científico publicado en 2020

IgA Responses Following Recurrent Influenza Virus Vaccination

artículo científico publicado en 2020

Infection of Ferrets with Influenza Virus Elicits a Light Chain-Biased Antibody Response against Hemagglutinin.

artículo científico publicado en 2017

Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV).

artículo científico publicado en 2009

Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII).

artículo científico publicado en 2012

Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV).

artículo científico publicado en 2010

Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein.

artículo científico publicado en 2012

Neutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape?

artículo científico publicado en 2012

New Insights for Immune-Based Diagnosis and Therapy for Infectious Diseases.

artículo científico publicado en 2017

New therapeutic options for HCV infection in the monoclonal antibody era

artículo científico publicado en 2012

Next Generation Vaccines for Infectious Diseases.

artículo científico publicado en 2019

Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides

artículo científico

Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections

artículo científico publicado en 2013

Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination

scientific article published on 16 January 2020

Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies

artículo científico publicado en 2013

The Answer Lies in the Energy: How Simple Atomistic Molecular Dynamics Simulations may Hold the Key to Epitope Prediction on the Fully Glycosylated SARS-CoV-2 Spike Protein

artículo científico publicado en 2020

Towards a universal influenza vaccine: different approaches for one goal

artículo científico publicado en 2018

Lista de obras de Giuseppe A. Sautto

A Biologically-validated HCV E1E2 Heterodimer Structural Model

A Computationally Optimized Broadly Reactive Antigen Subtype-Specific Influenza Vaccine Strategy Elicits Unique Potent Broadly Neutralizing Antibodies against Hemagglutinin

A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments.

Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections

Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines

An Influenza Virus Hemagglutinin Computationally Optimized Broadly Reactive Antigen Elicits Antibodies Endowed with Group 1 Heterosubtypic Breadth against Swine Influenza Viruses

Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference.

Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study

Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein.

Chimeric antigen receptor (CAR)-redirected T cells: is there a place for them in infectious diseases?

Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: epitope definition and implications in risk stratification of patients under natalizumab therapy

Convergent antibody evolution and clonotype expansion following influenza virus vaccination

Editorial: Immunotherapeutic and Immunoprophylactic Strategies for Infectious Diseases

Elicitation of Broadly Protective Antibodies following Infection with Influenza Viruses Expressing H1N1 Computationally Optimized Broadly Reactive Hemagglutinin Antigens

Entry inhibition of HSV-1 and -2 protects mice from viral lethal challenge

HCV E2 core structures and mAbs: something is still missing.

HCV proteins and immunoglobulin variable gene (IgV) subfamilies in HCV-induced type II mixed cryoglobulinemia: a concurrent pathogenetic role

Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral Genotypes

High-Yield Expression and Purification of Recombinant Influenza Virus Proteins from Stably-Transfected Mammalian Cell Lines

IgA Responses Following Recurrent Influenza Virus Vaccination

Infection of Ferrets with Influenza Virus Elicits a Light Chain-Biased Antibody Response against Hemagglutinin.

Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV).

Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII).

Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV).

Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein.

Neutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape?

New Insights for Immune-Based Diagnosis and Therapy for Infectious Diseases.

New therapeutic options for HCV infection in the monoclonal antibody era

Next Generation Vaccines for Infectious Diseases.

Peptide-based vaccinology: experimental and computational approaches to target hypervariable viruses through the fine characterization of protective epitopes recognized by monoclonal antibodies and the identification of T-cell-activating peptides

Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections

Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination

Structural and antigenic definition of hepatitis C virus E2 glycoprotein epitopes targeted by monoclonal antibodies

The Answer Lies in the Energy: How Simple Atomistic Molecular Dynamics Simulations may Hold the Key to Epitope Prediction on the Fully Glycosylated SARS-CoV-2 Spike Protein

Towards a universal influenza vaccine: different approaches for one goal